| Produkt | Kod | Cena | ||
|---|---|---|---|---|
| Cetuximab (anti-EGFR) | A2000 5mg | 5mg |
€ 838,01 | Skontaktuj się z nami |
| Cetuximab (anti-EGFR) | A2000 1mg | 1mg |
€ 280,14 | Skontaktuj się z nami |
| Ipilimumab (anti-CTLA-4) | A2001 5mg | 5mg |
€ 2.369,12 | Skontaktuj się z nami |
| Ipilimumab (anti-CTLA-4) | A2001 20mg | 20mg |
€ 6.632,80 | Skontaktuj się z nami |
| Ipilimumab (anti-CTLA-4) | A2001 1mg | 1mg |
€ 790,91 | Skontaktuj się z nami |
| Nivolumab (anti-PD-1) | A2002 5mg | 5mg |
€ 838,01 | Skontaktuj się z nami |
| Ramucirumab (anti-VEGFR2) | A2003 5mg | 5mg |
€ 838,01 | Skontaktuj się z nami |
| Atezolizumab (anti-PD-L1) | A2004 5mg | 5mg |
€ 838,01 | Skontaktuj się z nami |
| Atezolizumab (anti-PD-L1) | A2004 25mg | 25mg |
€ 2.514,02 | Skontaktuj się z nami |
| Pembrolizumab (anti-PD-1) | A2005 5mg | 5mg |
€ 838,01 | Skontaktuj się z nami |
| Bevacizumab (anti-VEGF) | A2006 5mg | 5mg |
€ 838,01 | Skontaktuj się z nami |
| Bevacizumab (anti-VEGF) | A2006 1mg | 1mg |
€ 280,14 | Skontaktuj się z nami |
Selleckchem Chemicals
Selleck Chemicals supplies over 120,000 inhibitors used in the study of cell signaling pathways. We actively tracks the latest science so our customers can rely on us to be the leading supplier of the newest inhibitors. Selleck's Bioactive Screening Libraries consist of over 8,000 small molecules with validated biological and pharmacological activities. The safety and effectiveness of these molecules has been demonstrated through preclinical and clinical research and many of them are FDA-approved compounds.
More information?Contact Us by e-mail info@divbio.pl